eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Revised Guidance on Marketed Unapproved Drugs; Availability: Marketed New Drugs Without Approved NDAs or ANDAs

Revised Guidance on Marketed Unapproved Drugs; Availability: Marketed New Drugs Without Approved NDAs or ANDAs

Document ID: FDA-2011-D-0633-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2011-24316
CFR Citation: 21 CFR Chapter I
View Document:  View as format pdf View as format html

Details Information

Document Subtype: Notice of Availability
Received Date: September 19 2011, at 12:00 AM Eastern Daylight Time
Start-End Page: 58398 - 58399
Page Count: 2
Comment Start Date: September 21 2011, at 12:00 AM Eastern Standard Time

Comments

Total: 0
No comments posted.

Related Documents

    More
Total: 15
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Administrative Detention under the Food and Drug Administration Safety and Innovation Act
Tobacco Product Manufacturing Practice; Establishment of a Public Docket